Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with 150 liver resections.

S Iwatsuki, B W Shaw, T E Starzl

    Annals of Surgery
    |March 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    This study on liver resections found a 4% operative mortality. Survival rates were 56% for primary liver cancer and 66% for metastatic tumors, with most benign cases remaining symptom-free.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Appropriate management of high-flow priapism based on color Doppler ultrasonography findings in pediatric patients: four case reports and a review of the literature.

    Journal of pediatric urology·2019
    Same author

    Chromosomal anomalies and sperm retrieval outcomes of patients with non-obstructive azoospermia: a case series.

    Andrology·2017
    Same author

    Effect of obesity on sperm retrieval outcome and reproductive hormone levels in Japanese azoospermic men with and without Klinefelter syndrome.

    Andrology·2016
    Same author

    Liver Resection for Primary Hepatic Neoplasms.

    Acta chirurgica Austriaca·2013
    Same author

    WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation.

    Hospital record study : a joint study by CPHA and IMS America Ltd·2011
    Same author

    Hepatic Homograft Survival in Pediatric Orthotopic Liver Transplantation with Cyclosporine and Steroids.

    Transplantation proceedings·2010
    Same journal

    The International Medical Graduate Paradox.

    Annals of surgery·2026
    Same journal

    Defining the Incremental Value of Endoscopic Ultrasound in Assessing Pancreatic Cystic Neoplasms.

    Annals of surgery·2026
    Same journal

    Trends in Metabolic and Bariatric Surgery and GLP-1 Receptor Agonist Use Among Adolescents with Severe Obesity.

    Annals of surgery·2026
    Same journal

    The Ambulatory Surgery Center Paradox: Why 60% of Surgeries Occur Where 2% of AI Research Happens.

    Annals of surgery·2026
    Same journal

    Medical Student First Authorship in High-Impact Surgical Journals: Longitudinal Trends and Institutional Concentration, 2000-2025.

    Annals of surgery·2026
    Same journal

    Radial Margin Distance in Perihilar Cholangiocarcinoma: Defining Dual Cutoff Values of 0 and 1 mm.

    Annals of surgery·2026
    See all related articles

    Area of Science:

    • Hepatobiliary Surgery
    • Surgical Oncology
    • Gastroenterology

    Background:

    • Liver resections are a critical treatment for various liver conditions.
    • Understanding outcomes is vital for patient management and surgical planning.

    Purpose of the Study:

    • To evaluate the outcomes and survival rates following liver resections.
    • To analyze results based on indications: primary malignancies, metastatic tumors, and benign diseases.

    Main Methods:

    • Retrospective analysis of 150 liver resection cases.
    • Data collection on operative mortality, indications, and long-term survival.
    • Actuarial survival rates calculated for malignancy groups.

    Main Results:

    Related Experiment Videos

  • Operative mortality was 4% across all liver resections.
  • Indications included primary liver malignancies (43), metastatic liver tumors (43), and benign diseases (64).
  • Three-year survival: 56% for primary malignancy, 66% for metastatic tumors. Benign cases showed excellent long-term outcomes.

    • Conclusions:

    • Liver resection is a viable treatment with acceptable mortality.
    • Favorable survival rates are achievable for both primary and metastatic liver tumors.
    • Benign liver disease resections offer excellent long-term results with minimal complications.